Share-based Payment Arrangement, Expense of HilleVax, Inc. from 31 Dec 2021 to 30 Jun 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
- Summary
-
HilleVax, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2021 to 30 Jun 2025.
- HilleVax, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2025 was $2,330,000, a 62% decline year-over-year.
- HilleVax, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2025 was $14,288,000, a 25% decline year-over-year.
- HilleVax, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $20,784,000, a 53% increase from 2023.
- HilleVax, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13,590,000, a 353% increase from 2022.
- HilleVax, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3,003,000, a 4382% increase from 2021.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
HilleVax, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2025 | $14,288,000 | $2,330,000 | -$3,731,000 | -62% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 06 Aug 2025 | 2025 | Q2 |
| Q1 2025 | $18,019,000 | $2,429,000 | -$2,765,000 | -53% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 08 May 2025 | 2025 | Q1 |
| Q4 2024 | $20,784,000 | $4,479,000 | +$723,000 | +19% | 01 Oct 2024 | 31 Dec 2024 | 10-K | 28 Mar 2025 | 2024 | FY |
| Q3 2024 | $20,061,000 | $5,050,000 | +$1,104,000 | +28% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 07 Nov 2024 | 2024 | Q3 |
| Q2 2024 | $18,957,000 | $6,061,000 | +$2,815,000 | +87% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 06 Aug 2025 | 2025 | Q2 |
| Q1 2024 | $16,142,000 | $5,194,000 | +$2,552,000 | +97% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 08 May 2025 | 2025 | Q1 |
| Q4 2023 | $13,590,000 | $3,756,000 | +$2,425,000 | +182% | 01 Oct 2023 | 31 Dec 2023 | 10-K | 28 Mar 2025 | 2024 | FY |
| Q3 2023 | $11,165,000 | $3,946,000 | +$3,102,000 | +368% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 07 Nov 2024 | 2024 | Q3 |
| Q2 2023 | $8,063,000 | $3,246,000 | +$2,690,000 | +484% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 09 Aug 2024 | 2024 | Q2 |
| Q1 2023 | $5,373,000 | $2,642,000 | +$2,370,000 | +871% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2024 | 2024 | Q3 |
| Q4 2022 | $3,003,000 | $1,331,000 | 01 Oct 2022 | 31 Dec 2022 | 10-K | 20 Mar 2024 | 2023 | FY | ||
| Q3 2022 | $844,000 | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 09 Nov 2023 | 2023 | Q3 | |||
| Q2 2022 | $556,000 | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 14 Aug 2023 | 2023 | Q2 | |||
| Q1 2022 | $272,000 | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 12 May 2023 | 2023 | Q1 |
HilleVax, Inc. Annual Share-based Payment Arrangement, Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | $20,784,000 | +$7,194,000 | +53% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 28 Mar 2025 | 2024 | FY |
| 2023 | $13,590,000 | +$10,587,000 | +353% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 28 Mar 2025 | 2024 | FY |
| 2022 | $3,003,000 | +$2,936,000 | +4382% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 20 Mar 2024 | 2023 | FY |
| 2021 | $67,000 | 01 Jan 2021 | 31 Dec 2021 | 10-K | 17 Mar 2023 | 2022 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.